stockrowKiniksa Pharmaceuticals International, plc
KNSA Healthcare Drug Manufacturers Specialty & Generic
Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024.
- Revenue
- +58.1%
- EPS
- +142.2%
- Free cash flow
- +43.5%
Quarter to September 2026, against a year earlier
Follow KNSA
Alert me
Kiniksa Pharmaceuticals International, plc (KNSA) Gross margin
Kiniksa Pharmaceuticals International, plc's gross margin over the twelve months to 30 September 2026 was 90.2%, up 1.6 percentage points from fiscal 2025 (88.5%). Over the past ten years it has ranged from 0.00% (fiscal 2020) to 89.6% (fiscal 2022); the current reading is higher than 90% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 88.5% | 2.93 |
| FY2024 | 85.6% | (2.03) |
| FY2023 | 87.6% | (1.96) |
| FY2022 | 89.6% | 13.21 |
| FY2021 | 76.4% | 76.39 |
| FY2020 | 0.00% | 0.00 |
| FY2019 | 0.00% | 0.00 |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | 0.00 |
| FY2016 | 0.00% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 90.3% | (0.03) |
| Jun 2026 | 90.3% | 0.03 |
| Mar 2026 | 90.3% | 0.65 |
| Dec 2025 | 89.6% | 0.84 |
| 24 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| LQDA Liquidia Corporation compare | 92.5% |
| KNSA Kiniksa Pharmaceuticals International, plc | 90.2% |
| SUPN Indivior Pharmaceuticals Inc. compare | 84.9% |
| ALKS Alkermes plc compare | 82.9% |
| HIMS Hims & Hers Health, Inc. compare | 68.4% |
| LNTH Lantheus Holdings, Inc. compare | 61.3% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 40.2% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on KNSA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement